What is the rationale and evidence that supports prompt, intensive, severity-of-disease-appropriate management of moderate-to-severe AD in the pediatric and adolescent age group?

What is the rationale and evidence that supports prompt, intensive, severity-of-disease-appropriate management of moderate-to-severe AD in the pediatric and adolescent age group?

What is the rationale and evidence that supports prompt, intensive, severity-of-disease-appropriate management of moderate-to-severe AD in the pediatric and adolescent age group?


Created by

CMEducation Resources iQ&A Case-By-Case Atopic Dermatitis Medical Intelligence Zone

Presenter

Lawrence Eichenfield, MD

Lawrence Eichenfield, MD

Chief of Pediatric and Adolescent Dermatology
Rady Children's Hospital-San Diego
Vice Chair, Department of Dermatology
Professor of Dermatology and Pediatrics
UC San Diego School of Medicine